肝细胞癌微环境的空间异质性决定了免疫治疗的有效性

Minni Zhang1,2, Kailin Huang1, Qiushi Yin1

  • 1Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical University, Haikou, 571199, Hainan, People's Republic of China.

Discover oncology
|January 8, 2025
PubMed
概括

肝细胞癌 (HCC) 治疗受到其免疫耐受性的限制. 了解肝癌免疫微环境的空间异质性是提高免疫疗法疗效和患者治疗结果的关键.